Vascular Solutions (VASC)
Vascular Solutions Earnings Per Share Growth: 20.00%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
VASC Earnings Per Share Growth Rankings
| Overall | 60th percentile | 1099 of 2775 |
| Sector | 66th percentile | 67 of 201 in Healthcare |
| Industry | 76th percentile | 7 of 30 in Medical Instruments & Supplies |
VASC Earnings Per Share Growth Range, Past 5 Years
| Minimum | -90.22% | Dec 2009 |
| Maximum | 1740% | Dec 2008 |
| Average | 255.3% |
About EPS Growth
YCharts EPS growth rates are calculated as quarterly year on year growth rates.
EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. EPS growth rates help investors identify stocks that are increasing or decreasing in profitability.
If a company has an EPS of $5.00 in 2008 and EPS of $6.00 in 2009, the company has an EPS growth rate of $6.00/$5.00 - 1 = 20% during fiscal year 2009.
Learn More
You may also be interested in these VASC related companies
VASC News
Mentioned $AUTH here in January. Believe has much more potential. Look at $VASC, especially weekly and monthly charts.
about 3 days ago by StrongestStocks
about 3 days ago by StrongestStocks
Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference
May 21, 4:05PM GlobeNewswire
May 21, 4:05PM GlobeNewswire
Vascular Solutions to Participate in the 2012 InvestMNt Conference Sponsored by the CFA Society of Minnesota
May 10, 4:05PM GlobeNewswire
May 10, 4:05PM GlobeNewswire
Benchmark Starts Vascular Solutions (VASC) at Buy; Catheter Products are Key
May 08, 7:29AM Street Insider
May 08, 7:29AM Street Insider
Vascular Solutions to Participate in Bank of America Merrill Lynch 2012 Health Care Conference
May 01, 4:05PM GlobeNewswire
May 01, 4:05PM GlobeNewswire
Dougherty & Co Upgrades Vascular Solutions (VASC) to Buy; Strong Q1 and Improved Outlook
Apr 25, 11:07AM Street Insider
Apr 25, 11:07AM Street Insider
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Raising PT After Strong Results
Apr 25, 9:44AM Street Insider
Apr 25, 9:44AM Street Insider
Listen to $VASC Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3USg
about 38 days ago by earningscast
about 38 days ago by earningscast
Vascular Solutions, Inc. (VASC) Tops Q1 EPS by 1c; Guides for Q2 and FY
Apr 24, 4:16PM Street Insider
Apr 24, 4:16PM Street Insider
Vascular Solutions, Inc. to Webcast First Quarter Conference Call on Tuesday, April 24th at 3:30pm CST
Apr 10, 4:05PM Business Wire
Apr 10, 4:05PM Business Wire
$VASC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3A4Q
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
$VASC forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2x79
about 74 days ago by RecogniaEvents
about 74 days ago by RecogniaEvents
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Q4 Mixed; 2012 Looks Like Transition Year
Feb 02, 9:33AM Street Insider
Feb 02, 9:33AM Street Insider
$VASC Q4 revs +6%, EPS +8% (ex-tax benefit), maintains 2012 guidance http://stks.co/2CR4 (no pos)
about 121 days ago by wallstreetbean
about 121 days ago by wallstreetbean
Listen to $VASC Q4 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2CLA
about 121 days ago by earningscast
about 121 days ago by earningscast
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Feb 01, 4:20PM Street Insider
Feb 01, 4:20PM Street Insider
Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters
Feb 01, 4:05PM GlobeNewswire
Feb 01, 4:05PM GlobeNewswire
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call on Wednesday, February 1st at 3:30 p.m. CST
Jan 18, 4:05PM Business Wire
Jan 18, 4:05PM Business Wire
BeanScreen for January 1, 2012 | via @WallStreetBean http://stks.co/1jUG $VASC $CVX $QCOR $CHL
about 152 days ago by STNet
about 152 days ago by STNet
Vascular Solutions to Present at the 23rd Annual Piper Jaffray Health Care Conference
Nov 22, 4:15PM GlobeNewswire
Nov 22, 4:15PM GlobeNewswire
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Mixed Q3 and Underwhelming Guidance
Oct 26, 8:45AM Street Insider
Oct 26, 8:45AM Street Insider
Vascular Solutions, Inc. (VASC) Tops Q3 EPS by 2c, Posts Q4 and FY12 Guidance, Raises FY11
Oct 25, 4:40PM Street Insider
Oct 25, 4:40PM Street Insider
weekly chart. still looking to trade this one long if we get a break above 12.6 $VASC http://chart.ly/9rmo24o
about 249 days ago by jasonbgordon
about 249 days ago by jasonbgordon
$VASC broke out of bull flag - love the name - had in depth report on it few weeks ago
about 605 days ago by OptionRadar
about 605 days ago by OptionRadar
$VASC http://chart.ly/7ap75u4 Vascular Solutions a Fantastic 6.5 Year Chart, Posted 2 Months Back as Takeover Play, Still Believe
about 642 days ago by OptionRadar
about 642 days ago by OptionRadar
$VASC big breakout of double top going back 10 years - looks to be attractive takeover candidate
about 716 days ago by OptionRadar
about 716 days ago by OptionRadar
http://chart.ly/ygnfpz $VASC - Thinly traded & small market cap, but co just made acquisition & raised EPS guidance. One to watch
about 737 days ago by ToddinFL
about 737 days ago by ToddinFL
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| VASC | 11.10 | -0.28 | -2.46% | 189.14M |
| UWN | 1.14 | +0.00 | +0.00% | 18.11M |
| UWBK | None | None | None | |
| UVV | 44.11 | -1.06 | -2.35% | 1.050B |
| UVSP | 15.45 | -0.57 | -3.56% | 268.34M |
| UVE | 3.60 | +0.10 | +2.86% | 140.42M |
| UUU | 5.02 | -0.08 | -1.57% | 11.80M |
| UDRL | 4.53 | -0.10 | -2.16% | 116.81M |
| UDR | 25.36 | -0.55 | -2.10% | 5.785B |
| UDOW | 42.97 | -3.08 | -6.69% |
